Synopsis
Synopsis
0
EU WC
0
NDC API
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cfobis
2. Cefobid
3. Cefoperazon
4. Cefoperazone
5. Cefoperazone Sodium Salt
6. Salt, Cefoperazone Sodium
7. Sodium Salt, Cefoperazone
8. Sodium, Cefoperazone
9. T 1551
10. T-1551
11. T1551
1. 62893-20-3
2. Sodium Cefoperazone
3. Cefoperazone Sodium Salt
4. Cefobid
5. Tomabef
6. T-1551
7. Cp 52640-2
8. Cefoperazone (sodium Salt)
9. Cefoperazone (as Sodium)
10. 5fqg9774wd
11. Chebi:3494
12. Cp-52,640-2
13. Nsc-758173
14. 62893-20-3 (sodium)
15. Cp-526402
16. Cefobid (tn)
17. Cp-52640-2
18. Dsstox_cid_25874
19. Dsstox_rid_81192
20. Dsstox_gsid_45874
21. Sodium;(6r,7r)-7-[[(2r)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
22. Cefobis
23. 1094606-34-4
24. Cas-62893-20-3
25. Cefobid In Plastic Container
26. Einecs 263-751-5
27. T 1551
28. Unii-5fqg9774wd
29. Cefoperazin
30. Cefoneg
31. Cefoper
32. Cefoperazon-natrium
33. Ncgc00094952-01
34. Cefobid Sodium Salt
35. Sodium;(6r,7r)-7-[[(2r)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxy
36. Cefoperazone Sodium [usan:usp:jan]
37. Cefoperazone, Sodium Salt
38. Sodium (6r,7r)-7-((r)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-(p-hydroxyphenyl)acetamido)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
39. Schembl537680
40. Chembl1200482
41. Dtxsid6045874
42. Hy-b0210a
43. Cefoperazone Sodium [jan]
44. Cefoperazone Sodium (jp17/usp)
45. Cefoperazone Sodium [usan]
46. Cefoperazone Sodium [vandf]
47. Cefoperazone Sodium [mart.]
48. Tox21_111367
49. Cefoperazone Sodium [who-dd]
50. Mfcd07793331
51. Cefoperazone Sodium Salt [mi]
52. Akos015951266
53. Tox21_111367_1
54. Ccg-270350
55. Cs-5023
56. Nsc 758173
57. Cefoperazone Sodium [ep Impurity]
58. Cefoperazone Sodium [orange Book]
59. Ncgc00179599-03
60. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, Monosodium Salt, (6r-(6alpha,7beta(r*)))-
61. Cefoperazone Sodium [ep Monograph]
62. Cefoperazone Sodium [usp Monograph]
63. C08112
64. D00918
65. Sulperazone Component Cefoperazone Sodium
66. A834072
67. Cefoperazone Sodium Component Of Sulperazone
68. Q27106107
69. Cefoperazone Sodium 100 Microg/ml In Acetonitrile:water
70. (6r,7r)-7-[[(2r)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
71. Sodium (6r,7r)-7-((r)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-(p-hydroxyphenyl)acetamido-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
72. Sodium (6r,7r)-7-((r)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-(4-hydroxyphenyl)acetamido)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
73. Sodium (6r,7r)-7-((r)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1h-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
74. Sodium 7-[[2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
75. Sodium(6r,7r)-7-((r)-2-(4-ethyl-2,3-dioxopiperazine-1-carboxamido)-2-(4-hydroxyphenyl)acetamido)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
| Molecular Weight | 667.7 g/mol |
|---|---|
| Molecular Formula | C25H26N9NaO8S2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 9 |
| Exact Mass | 667.12434545 g/mol |
| Monoisotopic Mass | 667.12434545 g/mol |
| Topological Polar Surface Area | 274 Ų |
| Heavy Atom Count | 45 |
| Formal Charge | 0 |
| Complexity | 1250 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
40
PharmaCompass offers a list of Cefoperazone Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefoperazone Sodium manufacturer or Cefoperazone Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefoperazone Sodium manufacturer or Cefoperazone Sodium supplier.
PharmaCompass also assists you with knowing the Cefoperazone Sodium API Price utilized in the formulation of products. Cefoperazone Sodium API Price is not always fixed or binding as the Cefoperazone Sodium Price is obtained through a variety of data sources. The Cefoperazone Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CEFOBID IN PLASTIC CONTAINER manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CEFOBID IN PLASTIC CONTAINER, including repackagers and relabelers. The FDA regulates CEFOBID IN PLASTIC CONTAINER manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CEFOBID IN PLASTIC CONTAINER API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CEFOBID IN PLASTIC CONTAINER manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CEFOBID IN PLASTIC CONTAINER supplier is an individual or a company that provides CEFOBID IN PLASTIC CONTAINER active pharmaceutical ingredient (API) or CEFOBID IN PLASTIC CONTAINER finished formulations upon request. The CEFOBID IN PLASTIC CONTAINER suppliers may include CEFOBID IN PLASTIC CONTAINER API manufacturers, exporters, distributors and traders.
click here to find a list of CEFOBID IN PLASTIC CONTAINER suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CEFOBID IN PLASTIC CONTAINER DMF (Drug Master File) is a document detailing the whole manufacturing process of CEFOBID IN PLASTIC CONTAINER active pharmaceutical ingredient (API) in detail. Different forms of CEFOBID IN PLASTIC CONTAINER DMFs exist exist since differing nations have different regulations, such as CEFOBID IN PLASTIC CONTAINER USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CEFOBID IN PLASTIC CONTAINER DMF submitted to regulatory agencies in the US is known as a USDMF. CEFOBID IN PLASTIC CONTAINER USDMF includes data on CEFOBID IN PLASTIC CONTAINER's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CEFOBID IN PLASTIC CONTAINER USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CEFOBID IN PLASTIC CONTAINER suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The CEFOBID IN PLASTIC CONTAINER Drug Master File in Japan (CEFOBID IN PLASTIC CONTAINER JDMF) empowers CEFOBID IN PLASTIC CONTAINER API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the CEFOBID IN PLASTIC CONTAINER JDMF during the approval evaluation for pharmaceutical products. At the time of CEFOBID IN PLASTIC CONTAINER JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of CEFOBID IN PLASTIC CONTAINER suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CEFOBID IN PLASTIC CONTAINER Drug Master File in Korea (CEFOBID IN PLASTIC CONTAINER KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CEFOBID IN PLASTIC CONTAINER. The MFDS reviews the CEFOBID IN PLASTIC CONTAINER KDMF as part of the drug registration process and uses the information provided in the CEFOBID IN PLASTIC CONTAINER KDMF to evaluate the safety and efficacy of the drug.
After submitting a CEFOBID IN PLASTIC CONTAINER KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CEFOBID IN PLASTIC CONTAINER API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CEFOBID IN PLASTIC CONTAINER suppliers with KDMF on PharmaCompass.
A CEFOBID IN PLASTIC CONTAINER CEP of the European Pharmacopoeia monograph is often referred to as a CEFOBID IN PLASTIC CONTAINER Certificate of Suitability (COS). The purpose of a CEFOBID IN PLASTIC CONTAINER CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of CEFOBID IN PLASTIC CONTAINER EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of CEFOBID IN PLASTIC CONTAINER to their clients by showing that a CEFOBID IN PLASTIC CONTAINER CEP has been issued for it. The manufacturer submits a CEFOBID IN PLASTIC CONTAINER CEP (COS) as part of the market authorization procedure, and it takes on the role of a CEFOBID IN PLASTIC CONTAINER CEP holder for the record. Additionally, the data presented in the CEFOBID IN PLASTIC CONTAINER CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the CEFOBID IN PLASTIC CONTAINER DMF.
A CEFOBID IN PLASTIC CONTAINER CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. CEFOBID IN PLASTIC CONTAINER CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of CEFOBID IN PLASTIC CONTAINER suppliers with CEP (COS) on PharmaCompass.
CEFOBID IN PLASTIC CONTAINER Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CEFOBID IN PLASTIC CONTAINER GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CEFOBID IN PLASTIC CONTAINER GMP manufacturer or CEFOBID IN PLASTIC CONTAINER GMP API supplier for your needs.
A CEFOBID IN PLASTIC CONTAINER CoA (Certificate of Analysis) is a formal document that attests to CEFOBID IN PLASTIC CONTAINER's compliance with CEFOBID IN PLASTIC CONTAINER specifications and serves as a tool for batch-level quality control.
CEFOBID IN PLASTIC CONTAINER CoA mostly includes findings from lab analyses of a specific batch. For each CEFOBID IN PLASTIC CONTAINER CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CEFOBID IN PLASTIC CONTAINER may be tested according to a variety of international standards, such as European Pharmacopoeia (CEFOBID IN PLASTIC CONTAINER EP), CEFOBID IN PLASTIC CONTAINER JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CEFOBID IN PLASTIC CONTAINER USP).
